Copyright Reports & Markets. All rights reserved.

Global Veterinary Biologics Market Research Report 2021

Request for Sample of this report
Buy now

1 Veterinary Biologics Market Overview

  • 1.1 Product Overview and Scope of Veterinary Biologics
  • 1.2 Veterinary Biologics Segment by Type
    • 1.2.1 Global Veterinary Biologics Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Vaccines
    • 1.2.3 Monoclonal Antibodies
  • 1.3 Veterinary Biologics Segment by Application
    • 1.3.1 Veterinary Biologics Sales Comparison by Application: (2021-2027)
    • 1.3.2 Llivestock
    • 1.3.3 Equine
    • 1.3.4 Other
  • 1.4 Global Veterinary Biologics Market Size Estimates and Forecasts
    • 1.4.1 Global Veterinary Biologics Revenue 2016-2027
    • 1.4.2 Global Veterinary Biologics Sales 2016-2027
    • 1.4.3 Veterinary Biologics Market Size by Region: 2016 Versus 2021 Versus 2027

2 Veterinary Biologics Market Competition by Manufacturers

  • 2.1 Global Veterinary Biologics Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Veterinary Biologics Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Veterinary Biologics Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Veterinary Biologics Manufacturing Sites, Area Served, Product Type
  • 2.5 Veterinary Biologics Market Competitive Situation and Trends
    • 2.5.1 Veterinary Biologics Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Veterinary Biologics Players Market Share by Revenue
    • 2.5.3 Global Veterinary Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Veterinary Biologics Retrospective Market Scenario by Region

  • 3.1 Global Veterinary Biologics Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Veterinary Biologics Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Veterinary Biologics Market Facts & Figures by Country
    • 3.3.1 North America Veterinary Biologics Sales by Country
    • 3.3.2 North America Veterinary Biologics Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Veterinary Biologics Market Facts & Figures by Country
    • 3.4.1 Europe Veterinary Biologics Sales by Country
    • 3.4.2 Europe Veterinary Biologics Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Veterinary Biologics Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Veterinary Biologics Sales by Region
    • 3.5.2 Asia Pacific Veterinary Biologics Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Veterinary Biologics Market Facts & Figures by Country
    • 3.6.1 Latin America Veterinary Biologics Sales by Country
    • 3.6.2 Latin America Veterinary Biologics Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Veterinary Biologics Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Veterinary Biologics Sales by Country
    • 3.7.2 Middle East and Africa Veterinary Biologics Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Veterinary Biologics Historic Market Analysis by Type

  • 4.1 Global Veterinary Biologics Sales Market Share by Type (2016-2021)
  • 4.2 Global Veterinary Biologics Revenue Market Share by Type (2016-2021)
  • 4.3 Global Veterinary Biologics Price by Type (2016-2021)

5 Global Veterinary Biologics Historic Market Analysis by Application

  • 5.1 Global Veterinary Biologics Sales Market Share by Application (2016-2021)
  • 5.2 Global Veterinary Biologics Revenue Market Share by Application (2016-2021)
  • 5.3 Global Veterinary Biologics Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Merck
    • 6.1.1 Merck Corporation Information
    • 6.1.2 Merck Description and Business Overview
    • 6.1.3 Merck Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Merck Product Portfolio
    • 6.1.5 Merck Recent Developments/Updates
  • 6.2 Zoetis
    • 6.2.1 Zoetis Corporation Information
    • 6.2.2 Zoetis Description and Business Overview
    • 6.2.3 Zoetis Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Zoetis Product Portfolio
    • 6.2.5 Zoetis Recent Developments/Updates
  • 6.3 Boehringer Ingelheim
    • 6.3.1 Boehringer Ingelheim Corporation Information
    • 6.3.2 Boehringer Ingelheim Description and Business Overview
    • 6.3.3 Boehringer Ingelheim Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Boehringer Ingelheim Product Portfolio
    • 6.3.5 Boehringer Ingelheim Recent Developments/Updates
  • 6.4 Ceva
    • 6.4.1 Ceva Corporation Information
    • 6.4.2 Ceva Description and Business Overview
    • 6.4.3 Ceva Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Ceva Product Portfolio
    • 6.4.5 Ceva Recent Developments/Updates
  • 6.5 CAHIC
    • 6.5.1 CAHIC Corporation Information
    • 6.5.2 CAHIC Description and Business Overview
    • 6.5.3 CAHIC Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 CAHIC Product Portfolio
    • 6.5.5 CAHIC Recent Developments/Updates
  • 6.6 HVRI
    • 6.6.1 HVRI Corporation Information
    • 6.6.2 HVRI Description and Business Overview
    • 6.6.3 HVRI Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 HVRI Product Portfolio
    • 6.6.5 HVRI Recent Developments/Updates
  • 6.7 Ringpu Biology
    • 6.6.1 Ringpu Biology Corporation Information
    • 6.6.2 Ringpu Biology Description and Business Overview
    • 6.6.3 Ringpu Biology Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Ringpu Biology Product Portfolio
    • 6.7.5 Ringpu Biology Recent Developments/Updates
  • 6.8 Yebio
    • 6.8.1 Yebio Corporation Information
    • 6.8.2 Yebio Description and Business Overview
    • 6.8.3 Yebio Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Yebio Product Portfolio
    • 6.8.5 Yebio Recent Developments/Updates
  • 6.9 DHN
    • 6.9.1 DHN Corporation Information
    • 6.9.2 DHN Description and Business Overview
    • 6.9.3 DHN Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 DHN Product Portfolio
    • 6.9.5 DHN Recent Developments/Updates
  • 6.10 WINSUN
    • 6.10.1 WINSUN Corporation Information
    • 6.10.2 WINSUN Description and Business Overview
    • 6.10.3 WINSUN Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 WINSUN Product Portfolio
    • 6.10.5 WINSUN Recent Developments/Updates
  • 6.11 Elanco/Eli Lilly
    • 6.11.1 Elanco/Eli Lilly Corporation Information
    • 6.11.2 Elanco/Eli Lilly Veterinary Biologics Description and Business Overview
    • 6.11.3 Elanco/Eli Lilly Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
    • 6.11.4 Elanco/Eli Lilly Product Portfolio
    • 6.11.5 Elanco/Eli Lilly Recent Developments/Updates
  • 6.12 Virbac
    • 6.12.1 Virbac Corporation Information
    • 6.12.2 Virbac Veterinary Biologics Description and Business Overview
    • 6.12.3 Virbac Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
    • 6.12.4 Virbac Product Portfolio
    • 6.12.5 Virbac Recent Developments/Updates
  • 6.13 Jinyu Bio-Technology
    • 6.13.1 Jinyu Bio-Technology Corporation Information
    • 6.13.2 Jinyu Bio-Technology Veterinary Biologics Description and Business Overview
    • 6.13.3 Jinyu Bio-Technology Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
    • 6.13.4 Jinyu Bio-Technology Product Portfolio
    • 6.13.5 Jinyu Bio-Technology Recent Developments/Updates
  • 6.14 ChengDu Tecbond
    • 6.14.1 ChengDu Tecbond Corporation Information
    • 6.14.2 ChengDu Tecbond Veterinary Biologics Description and Business Overview
    • 6.14.3 ChengDu Tecbond Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
    • 6.14.4 ChengDu Tecbond Product Portfolio
    • 6.14.5 ChengDu Tecbond Recent Developments/Updates
  • 6.15 CAVAC
    • 6.15.1 CAVAC Corporation Information
    • 6.15.2 CAVAC Veterinary Biologics Description and Business Overview
    • 6.15.3 CAVAC Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
    • 6.15.4 CAVAC Product Portfolio
    • 6.15.5 CAVAC Recent Developments/Updates
  • 6.16 Kyoto Biken
    • 6.16.1 Kyoto Biken Corporation Information
    • 6.16.2 Kyoto Biken Veterinary Biologics Description and Business Overview
    • 6.16.3 Kyoto Biken Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
    • 6.16.4 Kyoto Biken Product Portfolio
    • 6.16.5 Kyoto Biken Recent Developments/Updates
  • 6.17 FATRO
    • 6.17.1 FATRO Corporation Information
    • 6.17.2 FATRO Veterinary Biologics Description and Business Overview
    • 6.17.3 FATRO Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
    • 6.17.4 FATRO Product Portfolio
    • 6.17.5 FATRO Recent Developments/Updates
  • 6.18 Vaksindo
    • 6.18.1 Vaksindo Corporation Information
    • 6.18.2 Vaksindo Veterinary Biologics Description and Business Overview
    • 6.18.3 Vaksindo Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
    • 6.18.4 Vaksindo Product Portfolio
    • 6.18.5 Vaksindo Recent Developments/Updates
  • 6.19 Bio-Labs
    • 6.19.1 Bio-Labs Corporation Information
    • 6.19.2 Bio-Labs Veterinary Biologics Description and Business Overview
    • 6.19.3 Bio-Labs Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
    • 6.19.4 Bio-Labs Product Portfolio
    • 6.19.5 Bio-Labs Recent Developments/Updates
  • 6.20 Avimex Animal
    • 6.20.1 Avimex Animal Corporation Information
    • 6.20.2 Avimex Animal Veterinary Biologics Description and Business Overview
    • 6.20.3 Avimex Animal Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
    • 6.20.4 Avimex Animal Product Portfolio
    • 6.20.5 Avimex Animal Recent Developments/Updates

7 Veterinary Biologics Manufacturing Cost Analysis

  • 7.1 Veterinary Biologics Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Veterinary Biologics
  • 7.4 Veterinary Biologics Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Veterinary Biologics Distributors List
  • 8.3 Veterinary Biologics Customers

9 Veterinary Biologics Market Dynamics

  • 9.1 Veterinary Biologics Industry Trends
  • 9.2 Veterinary Biologics Growth Drivers
  • 9.3 Veterinary Biologics Market Challenges
  • 9.4 Veterinary Biologics Market Restraints

10 Global Market Forecast

  • 10.1 Veterinary Biologics Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Veterinary Biologics by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Veterinary Biologics by Type (2022-2027)
  • 10.2 Veterinary Biologics Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Veterinary Biologics by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Veterinary Biologics by Application (2022-2027)
  • 10.3 Veterinary Biologics Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Veterinary Biologics by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Veterinary Biologics by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Vaccines
    Monoclonal Antibodies

    Segment by Application
    Llivestock
    Equine
    Other

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    Merck
    Zoetis
    Boehringer Ingelheim
    Ceva
    CAHIC
    HVRI
    Ringpu Biology
    Yebio
    DHN
    WINSUN
    Elanco/Eli Lilly
    Virbac
    Jinyu Bio-Technology
    ChengDu Tecbond
    CAVAC
    Kyoto Biken
    FATRO
    Vaksindo
    Bio-Labs
    Avimex Animal

    Buy now